株式会社メドレックス
2 known investors
Find your way into 株式会社メドレックス
Sign up to find every way you can get introduced to 株式会社メドレックス
- Your email: who you already know at 株式会社メドレックス, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the 株式会社メドレックス team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.
Founders & leadership
YM
Yonehiro MatsumuraRepresentative Director & President
Investors · 2
Frequently asked questions
- What does 株式会社メドレックス do?
- MedRx is a Japanese pharmaceutical company developing new drugs based on transdermal delivery technologies such as its ILTS and NCTS platforms and microneedle arrays. It is a publicly listed company focused on creating novel therapeutics for patients with various diseases.
- Who are 株式会社メドレックス's investors?
- 株式会社メドレックス's investors include Nippon Venture Capital, SMBC Venture Capital.
